Product NDC: | 0703-4502 |
Proprietary Name: | Metoclopramide hydrochloride |
Non Proprietary Name: | Metoclopramide hydrochloride |
Active Ingredient(s): | 5 mg/mL & nbsp; Metoclopramide hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-4502 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073135 |
Marketing Category: | ANDA |
Start Marketing Date: | 19911201 |
Package NDC: | 0703-4502-04 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0703-4502-04) > 2 mL in 1 VIAL, SINGLE-DOSE (0703-4502-01) |
NDC Code | 0703-4502-04 |
Proprietary Name | Metoclopramide hydrochloride |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0703-4502-04) > 2 mL in 1 VIAL, SINGLE-DOSE (0703-4502-01) |
Product NDC | 0703-4502 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoclopramide hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19911201 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |